pLKO.1C Citations (3)
Originally described in: Improved third-generation lentiviral packaging with pLKO.1C vectors.Lee S, Cobrinik D Biotechniques. 2020 Jun;68(6):349-352. doi: 10.2144/btn-2019-0155. Epub 2020 Mar 6. PubMed Journal
Articles Citing pLKO.1C
Articles |
---|
RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis. Chen D, Ji F, Zhou Q, Cheung H, Pan Y, Lau HC, Liang C, Yang Z, Huang P, Wei Q, Cheung AH, Kang W, Chen H, Yu J, Wong CC. Cancer Res. 2024 Sep 4;84(17):2856-2872. doi: 10.1158/0008-5472.CAN-23-2081. PubMed |
ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt Pathway. Rodvold JJ, Grimmer M, Ruiz K, Marsters SA, Oikonomidi I, Tan-Aristy E, Pham VC, Sarkar T, Harnoss JM, Shatz-Binder W, Modrusan ZD, Wu TD, Lill JR, Villemure E, Rudolph J, de Sousa E Melo F, Ashkenazi A. Cancer Res Commun. 2024 Oct 1;4(10):2734-2755. doi: 10.1158/2767-9764.CRC-24-0268. PubMed |
Radiotherapy resistance driven by Asparagine endopeptidase through ATR pathway modulation in breast cancer. Morillo-Huesca M, G Lopez-Cepero I, Conesa-Bakkali R, Tome M, Watts C, Huertas P, Moreno-Bueno G, Duran RV, Martinez-Fabregas J. J Exp Clin Cancer Res. 2025 Feb 27;44(1):74. doi: 10.1186/s13046-025-03334-6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.